ArticleOncotarget2017

Molecular and functional characterization of a new 3' end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib.

Vittorio Perfetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.